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Abstract 
Background: Sickle cell disease (SCD) is the most common inherited blood 
disorder in the United States (Center of Disease Control and Prevention, 2016). There has 
been an increase in the life expectancy of individuals with SCD. However, individuals 
still experience a variety of serious medical complications and are at risk for 
developmental delays, cognitive difficulties, and/or academic deficits (e.g., Hogan et al., 
2006; Thompson et al, 2002). SCD management plans vary in intensity and invasiveness 
(Barakat et al., 2006). Despite the serious consequences, adherence to SCD management 
is highly variable. Given that SCD is a chronic illness with a complex treatment regimen 
and serious complications, it is important to assess the impact of the illness on 
individuals’ health related quality of life (HRQoL). Research has found that children with 
SCD experience poorer HRQoL compared to healthy peers (Dale et al., 2011). However, 
there is a lack of conclusive findings on the relationship between adherence and HRQoL 
among children with SCD. Additionally, limited studies have explored the potential 
moderation effects of health-related variables on the relationship between adherence and 
patient’s HRQoL in an SCD population (e.g., Fisak et al., 2010). 
Aims: The first aim of the current study was to examine the relationship between 
caregiver-report on adherence and child HRQoL in a school-age population with SCD. It 
was hypothesized that endorsement of more adherence would be positively related to 
child HRQoL. The second aim explored the potential moderation effect of cognitive 
functioning, academic functioning, and academic accommodations on the previous 
relationship, respectively. It was hypothesized there would be a stronger relationship 
between adherence and HRQoL for individuals who had a higher level of cognitive 
functioning as compared to individuals who had a lower level. Similarly, it was predicted 
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that there would be a stronger relationship between adherence and HRQoL for 
individuals who had higher levels of academic functioning as compared to individuals 
who had lower levels. Lastly, it was predicted that there would be a stronger relationship 
between adherence and HRQoL for individuals who received fewer academic 
accommodations comparing to individuals who received more accommodations. 
Methods: The current study utilized baseline data from a completed randomized 
controlled trial that examined the efficacy of a problem-solving intervention for families 
with a school-age child with SCD. Children and caregivers completed questionnaires 
assessing child HRQoL. Children were administered a performance-based measure of 
cognitive and academic functioning. Caregivers completed measures assessing child 
adherence. 
Results: The current study found mixed results on the relationship between 
adherence and HRQoL. From caregivers’ perspective, better adherence was associated 
with better HRQoL (r= .34, p= .002). No relationship was revealed based on child self-
report (r= -.01, p= .929). No significant moderation effects were found. However, 
academic functioning was positively associated with caregiver proxy-report on child 
HRQoL. Academic needs were negatively associated with caregiver proxy-report on 
child HRQoL, suggesting that increasing number of needed accommodations was 
associated with lower HRQoL.  
Conclusions: Child and caregiver informants reported different perspectives on 
child HRQoL and might assess child HRQoL differently as the child ages. Without strong 
communication between children and caregivers, caregivers may have a different 
understanding of their children’s overall HRQoL. This highlights the importance for 
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psychologists and health care workers of integrating different perspectives when 
discussing HRQoL. Adherence was only found to be significantly correlated with 
caregiver proxy-report on child HRQoL. Future research should further explore this 
relationship using different informants and continue to explore the potential influence of 
cognitive and academic functioning on adherence and HRQoL within a SCD population. 
Additional data may help us better understand how to improve children’s HRQoL and 
develop strategies for early detection and intervention. 
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Introduction 
Sickle cell disease (SCD) is the most common inherited blood disorder in the 
United States (National Human Genome Research Institute, 2016). One in 500 African 
American infants born in the United States is diagnosed with SCD (Brousseau et al., 
2010). SCD is a multisystem disease associated with episodes of acute illness and 
progressive organ damage (Rees et al., 2010). The term sickle cell disease is used to refer 
to a spectrum of different genotypes. Within the spectrum, sickle cell anemia (SCA) is 
the most common form of SCD (Rees et al., 2010). Genotypes Hb SS and Hb Sβ0 are 
more severe forms than Hb SC and Hb Sβ+ (Quinn, 2013). The genetic alternation 
responsible for SCD syndromes is a point mutation on the β globin gene (Rees et al., 
2010) in Hemoglobin A (HbA) which is the major oxygen-carrying protein in human red 
blood cells (Rees et al., 2010). Healthy red blood cells are disc-shaped, flexible, and carry 
oxygen through blood vessels. In individuals with SCD, the inflexible red blood cells 
form into a C-shape which can clog the flow of blood (Centers of Disease Control & 
Prevention, 2016). In addition, these deformed blood cells die earlier than healthy blood 
cells and this can then lead to a shortage of red blood cells in the body (Centers of 
Disease Control & Prevention, 2016).  
Prevalence  
SCD affects millions of people throughout the world and is especially common in 
individuals of African ancestry, but also occurs in descendants from Turkey, Greece, 
southern Mediterranean regions, Saudi Arabia, India, the Caribbean, and Latin America 
(Brawley et al., 2008). Within the United States, SCD affects approximately 100,000 
individuals and occurs in about 1 in every 365 African-American births (Centers for 
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Disease Control and Prevention, 2016). In addition, approximately 1 in 13 African-
American infants are born with sickle cell trait in which individuals inherit one sickle cell 
gene and one normal gene (Centers of Disease Control and Prevention, 2016). Individuals 
with sickle cell trait usually do not have any symptoms of SCD; however, they can pass 
the trait on to their children (Center of Disease Control and Prevention, 2016).  
Life Expectancy 
Life expectancy of individuals with SCD has been increasing due to 
improvements in the medical care of the illness. For HbSS and HbSβ0 patients, more 
severe forms of SCD, it was estimated overall survival at 18 years old to be 93.9% 
(Quinn et al., 2010). For HbSC and HbSβ+ patients, the estimated overall survival rate at 
18 years of age was 98.4% (Quinn et al., 2010). However, adolescents and young adults 
are at higher risk of death after transition to adult medical care, with a 22% decrease in 
mortality (Hamideh & Alvarez, 2013; Quinn et al., 2010). In contrast, children age 1-4 
years old had the greatest decline of 67% (Hamideh & Alvarez, 2013). Individuals with 
SCD experience a variety of serious medical complications including pain, infections, 
pulmonary and cardiac complications, and strokes.  
Primary Medical Complications Associated with SCD 
Pain. Individuals with SCD experience different types of pain, including vaso-
occlusive pain crises, chronic pain syndromes, and neuropathic pain (Ballas, Gupta, K, & 
Adams-Graves, 2012). The most common and significant complication of SCD involves 
vaso-occlusive pain which is recurrent and unpredictable episodes of pain (Rees et al., 
2010). These episodes of pain differ in intensity and locations (Franck et al., 2002) and 
may occur either spontaneously or as a consequence of environmental stress (e.g., 
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exposure to excessive cold or heat), physiological stress (e.g., infection, dehydration), or 
psychosocial stress (e.g., school exams, peer conflicts) (Ballas, 1998). Children and 
adolescents with SCD typically report pain on 7-30% of diary days, with an average 
duration of 2.5 days and an average pain rating of 5 on a 10-point scale (Dampier, Ely, 
Brodecki, & O’Neal, 2002; Gil et al., 2000). Pain episodes can interfere with day-to-day 
functioning including social activities and school attendance, especially in a school-age 
population (Barakat et al., 2006). The majority of pain episodes are managed at home 
with either pharmacological (e.g., analgesic medication) or nonpharmacological 
interventions (e.g., distracting activities such as sleeping, watching television), or some 
combination of both (Dampier et al., 2002). For nonpharmacological interventions, 
cognitive-behavioral techniques are considered efficacious for pain management (Gil et 
al., 1997). In addition, a case study of acceptance and commitment therapy also showed 
improvement in patient’s pain management and quality of life (Masuda et al., 2011). 
Infection. Complications due to infection are a major cause of morbidity and 
mortality in children with SCD. For example, individuals with SCD may experience 
infections due to impaired splenic function, defects in complement activation, 
micronutrient deficiencies, and tissue ischemia (Sergeant & Sergeant, 2001). Suggested 
prevention and interventions include vaccines, early detection, and antibiotic medications 
(Center of Disease Control and Prevention, 2016). 
Acute Chest Syndrome. With improved life expectancy in the SCD population, 
the impact of added disease activity on organ function is becoming more apparent (Castro 
et al., 1994). Acute chest syndrome is described as chest pain along with respiratory 
distress (Castro et al., 1994) and is the second most common cause of hospital admission 
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in patients with SCD (Rees et al., 2010). Treatments for acute chest syndrome include 
antibiotics, bronchodilators, and oxygen (Rees et al., 2010). 
Pulmonary Hypertension. Pulmonary hypertension is increasingly recognized as 
a complication in youth with SCD (Rees et al., 2010). Although there is currently no 
robust evidence on the best approach to treat this serious complication in patients with 
SCD, current treatments include regular blood transfusions and medications (Rees et al., 
2010), such as phosphodiesterase-5 inhibitors (e.g., sildenafil) (Mehari et al., 2012). 
Strokes and Other Neurological Complications. Silent cerebral infarcts are the 
most common form of neurological injury in children with SCD, occurring in 22-35% of 
kids by the age of 14 years (Miller et al., 2001). Overt strokes are seen in 9% of patients 
with SCD before their 14th birthday (Ohene-Frempong, 1991). The onset of overt strokes 
is generally abrupt, typically occurs within the large vessels, commonly involves both 
cortex and deep white matter, and is associated with greater neurocognitive deficits 
(Moser et al., 1996). The occurrence of strokes is also related to SCD genotypes. Stroke 
is much less common in Hb SC and Hb Sβ+ while individuals with Hb SS are at the 
highest risk of overt stroke (Quinn, 2013). Brown and colleagues (2000) found that, 
within a SCD sample, children with overt stroke or silent infarcts differed from those 
without any central nervous system pathology in attention and executive functioning. 
Additionally, children with overt stroke scored the lowest in intellectual functioning, 
academic achievement, and attention and executive functioning (Brown et al., 2000). 
Without proper management, over half of individuals with SCD and stroke experience 
progression of cerebrovascular injury or stroke recurrence (e.g., Mark & Thompson, 
2016; Ohene-Frempong, 1991). Long-term blood transfusion therapy is the most widely 
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accepted treatment for stroke prevention in patients with SCD who have previously 
experienced strokes (Ohene-Frempong, 1991). However, potential complications of 
blood transfusion are of concern, including infections (e.g., HIV, hepatitis), the 
development of antibodies to transfused blood cells, acute and delayed transfusion 
reactions, and iron overload (Ohene-Frempong, 1991). 
Cognitive and Academic Functioning 
Individuals with SCD of all ages are at risk for developmental delays, cognitive 
difficulties, and/or academic deficits (Lemanek, Ranalli, Roberts, & Steele, 2009). For 
instance, increased risk status or delay and/or slowed attainment of developmental skills 
(e.g., neurocognitive development) have been found in early childhood patients with SCD 
(e.g., Hogan et al., 2006; Thompson, Gustafson, Bonner, & Ware, 2002). In toddlers and 
preschoolers with SCD, deficits have been identified primarily in language, motor 
abilities, and executive functions (memory and attention) (Schatz & Roberts, 2007). 
Moreover, previous studies of children with SCD and overt strokes documented deficits 
on measures of general intelligence, language abilities, visual-motor skills, sequential 
memory, and attention (Armstrong et al., 1996). In addition, poor school performance has 
been found among children with silent infarcts (Schatz et al., 2001). A high percentage of 
students with SCD have reported that disease-related problems pose challenges for them 
in relation to participating in school (Peterson et al., 2005), and such students 
demonstrate a higher rate of grade retention and need for special educational services as 
compared to classmates without SCD (31% vs. 14%) (Schatz et al., 2001). Longitudinal 
studies have found that declines in global and specific neurocognitive functioning 
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increase with age in the presence of lower hematocrit levels (percentage of red blood 
cells in whole blood) (Kral et al., 2006).  
SCD Treatment and Management  
SCD treatment and management plans consist of pharmacological (e.g., 
analgesics, oral antibiotics) and non-pharmacological (e.g., hydration) treatments (Modi 
et al., 2009). Furthermore, as a chronic health condition, SCD requires patients and 
families to adhere and engage in a variety of daily disease management behaviors. 
Depending on the severity of complications, these management behaviors for SCD vary 
in intensity and invasiveness (Barakat et al., 2006). For example, management plans may 
involve direct management (i.e., taking prophylactic antibiotics and hydroxyurea) as well 
as preventive care (e.g., hydration, restrictions on physical activities, avoidance of 
extreme temperature) (Barakat et al., 2006). Regular blood transfusions are frequently 
required for children who have had stroke, are at risk for stroke, or experience severe 
pain crises (Barakat et al., 2006). Additionally, alternative treatment options for children 
with the most severe complications from the disease include treatment with hydroxyurea 
and/or bone marrow transplant (Barakat et al., 2006). However, research has found that 
adherence to SCD management plans is variable (Damper et al., 2002; Elliott, Morgan, 
Day, Mollerup, & Wang, 2001; Olivieri & Vichinsky, 1998; Witherspoon & Drotar, 
2006). Among pediatric population with asthma, researchers have suggested that 
children’s cognitive understanding of illness affects not only their adherence to direct 
management of the disease, but also preventive management (McQuaid et al., 2003). 
They found that adherence was negatively related to patient’s age and minority status 
(McQuaid et al., 2003).  
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Similarly, it has been suggested that children with SCD, particularly as they age 
into adolescence, are at increased risk for nonadherence to a prescribed disease 
management plan for various reasons that include: 1) stressors related to their ethnic 
minority status; 2) the burden of poverty that disproportionately affects African 
Americans; and, 3) the increased risk of internalizing problems (e.g., anxiety, depression) 
and academic challenges related to SCD (Baskin et al., 1998). The clinical characteristics 
of SCD and its treatment may also compromise consistent treatment adherence, 
especially for families with school-age children where problems with medication 
provision, nutrition, and minimizing pain frequently occur (e.g., Barakat et al., 2002). 
Transition to adult care is a high-risk period for mortality in adolescents and young adults 
with SCD (Quinn et al., 2010), which emphasizes early detection of and intervention on 
adherence barriers and the importance of addressing consistent adherence to treatment 
and management plans to patients and families.  
Health-related Quality of Life 
Health-related quality of life (HRQoL) is important for measuring the impact of 
chronic health conditions. It encompasses not only the physical health status of an 
individual, but also considers other aspects of life such as psychological state, income, 
level of independence, social relationships, and quality of the environment (Guyatt, 
Feeny, & Patrick, 1993). Some research findings suggest that children with SCD 
experience poorer HRQoL compared to healthy peers (Dale et al., 2011; Palermo et al., 
2002). However, studies that examined the relationship between adherence to treatment 
and child’s HRQoL in this population have produced mixed results. For example, Fisak 
and colleagues (2010) found a positive association between adherence and child’s 
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HRQoL in children with SCD. In contrast, results from another study found that better 
adherence was associated with poorer HRQoL, as higher levels of adherence may 
interfere with preferred physical and social activities (Barakat et al., 2005). Given the 
intensive treatment regimens and serious medical complications associated with SCD, it 
is important to further study the relationship between adherence behaviors and HRQoL in 
this pediatric population. Within a school-aged population, children start to take on 
responsibility in treatment adherence with better understanding of disease consequences, 
although adherence can be compromised when responsibilities outweigh the child’s 
intellectual capacity or maturity level (Wysocki et al., 1996). Penza-Clvve and colleagues 
(2009) conducted a qualitative study assessing children’s perspectives on adherence. 
Lack of motivation, difficulties remembering, and social barriers were identified (Penza-
Clvve et al., 2009). Children expressed burdens of taking medication in interfering with 
their daily activity and social interactions, especially when symptoms were not present 
(Penza-Clvve et al., 2009). Considering the variety of direct and preventative disease 
management children with SCD are required to adhere, it is important to assess the effect 
of adherence on patients’ overall well-being. 
Adherence Behaviors 
Operational definitions of adherence have varied with some researchers and 
clinicians applying a categorical approach whereby specific criteria or cutoff scores are 
used for “successful” adherence (e.g., Phipps & DeCuir-Whalley, 1990). Others have 
referred to adherence as, “the extent to which a person’s behavior, in terms of taking 
medications, following diets, or executing lifestyle changes, coincides with medical or 
health advice” (Haynes et al., 1979, pp.2-3). More recently, researchers have been trying 
9 
  
to come up with a definition that more accurately and comprehensively describes 
adherence. Kyngas and colleagues (2000) suggested that it is important to emphasize a 
person’s active role in the treatment process. Similarly, Schillerstrom and colleagues 
(2005) promoted the perspective that patients engage in self-care behaviors and respond 
to self-care demands versus passively comply with professional recommendations 
(Schillerstrom et al., 2005). Furthermore, Schillerstrom and colleagues (2005) found that 
self-care demands of children with neurological disorders or chronic medical conditions 
are further complicated by associated cognitive deficits (e.g., attention, processing speed, 
memory) that are thought to compromise the child’s overall ability to learn and 
consistently implement functional skills in the context of both typical and atypical 
demands. A child’s impaired ability to engage in self-care behaviors does not solely 
depend on his or her intelligence (Schillerstrom et al., 2005). For example, adolescents 
with spina bifida frequently encounter this self-care dilemma as the executive 
dysfunction associated with early hydrocephalus is thought to impact their ability to plan 
for and consistently implement both typical and atypical self-care tasks (e.g., self-
catheterization) (Tarazi et al., 2007). 
Current Study 
Rational. Research has shown that adherence to treatment among children 
afflicted with chronic health conditions is further complicated by associated cognitive 
deficits (e.g., attention, processing speed, memory) that can impair children’s overall 
ability to learn and consistently implement skills in meeting treatment and self-care 
demands (Schillerstrom et al., 2005). In their research study examining executive 
functioning as a key moderator in the development of self-care independence, Tarazi and 
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colleagues (2007) proposed that a child’s ability to compensate for such deficits in 
functioning domains (e.g., language, visuospatial processing, academic skills) is not 
solely dependent on the intelligence level and external support but also on the integrity of 
executive control functions. The current study adapted a similar perspective by 
suggesting that cognitive ability and academic skills might impact adherence behaviors 
(Kyngas et al., 2000; Schillerstrom et al., 2005). In particular, we were interested in the 
role of cognitive functioning as well as academic functioning in influencing children’s 
treatment adherence and its relationship with HRQoL. 
Despite serious health-related consequences, children with SCD do not endorse a 
consistently high level of adherence to treatment regimens (Damper et al., 2002; Elliott, 
Morgan, Day, Mollerup, & Wang, 2001; Olivieri & Vichinsky, 1998; Witherspoon & 
Drotar, 2006). There is limited research on the relationship between adherence behaviors 
and patients’ HRQoL in SCD populations. Moreover, few studies have explored the 
moderation effect of cognitive or academic variables on the relationship between 
adherence behaviors and patient’s HRQoL in this population (e.g., Barakat et al., 2005; 
Fisak et al., 2010). 
Study Aims and Hypotheses. The first aim of the current study was to examine 
the relationship between adherence behaviors and child HRQoL in school-age children 
with SCD. It was hypothesized that endorsing more adherence behaviors would be 
positively related to child HRQoL. The second aim would explore the potential 
moderation effect of cognitive functioning, academic functioning, and academic needs on 
the relationship between adherence behaviors and child HRQoL, respectively. It was 
predicted that there would be a stronger relationship between adherence behaviors and 
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HRQoL for individuals who had a higher level of cognitive functioning as compared to 
individuals who had a lower level of cognitive functioning. Similarly, it was predicted 
that there would be a stronger relationship between adherence behaviors and HRQoL for 
individuals who had higher levels of academic functioning as compared to individuals 
who had lower levels of academic achievement. Lastly, it was predicted that there would 
be a stronger relationship between adherence behaviors and HRQoL for individuals who 
received a lower number of academic accommodations as compared to individuals who 
received a higher number of academic accommodations. 
Methods 
The current study utilized baseline data from a previously completed randomized 
controlled trial (supported by NHLBI) that examined the efficacy of a problem-solving 
intervention for families with a school-aged child with SCD from one of two 
comprehensive sickle cell clinics in children’s hospitals in a northeastern city (Daniel et 
al., 2015). The study protocol was approved by the Human Subjects Committees of the 
Drexel Institutional Review Board (IRB). Participant recruitment was conducted between 
2009 and 2012. Data collection for the study was complete. The study protocol remains 
open for data analysis. 
Participants 
Children and their caregivers were eligible to participate in the original study if 
the child was between the ages of 6 and 12 years, had a diagnosis of SCD, spoke English 
as the primary language and received follow-up care at one of two children’s hospitals in 
a northeastern city in the United States. Exclusion criteria for the study included the 
presence of a developmental disability or severe psychopathology in either caregivers or 
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children that would negatively affect their ability to participate in the problem-solving 
intervention. However, children with less severe behavioral or developmental concerns 
(e.g., attention-deficit/hyperactivity disorder, anxiety disorder, reading problems) were 
eligible for the study. 
Eighty-two child-caregiver dyads were included in the current analysis. One 
family was excluded from the current study due to missing information on child HRQoL 
rating. Children ranged in age from 6 to 12 years (50% Female, M=8.49, SD=2.12). The 
majority of the child participants identified themselves as African-American/Black and 
Non-Hispanic (93.9%) and had a more severe SCD genotype HbSS (59.8%) (see Table 
1). The majority of the participating caregivers were female (N=77, 93.9%), identified 
themselves as African-American/Black (N=78, 95.1%), and had at least some high school 
education (N=82, 100%) (see Table 1). 
Measures 
The Self Care Inventory-Sickle Cell. The Self Care Inventory-Sickle Cell (SCI-
SC; Hilker, Jordan, Jensen, Elkin, & Iyer, 2006) is 19-item questionnaire that measures 
level of adherence in SCD care behaviors. The caregiver rates how well their child 
follows doctor’s instructions for their care on a 5-point Likert scale. Subscales for the 
SCI-SC consist of General Health Behavior, Sickle Cell Management, and Pain 
Management. The total score was used in the current study as it encompassed all three 
subscales and a separate nutrition score which was computed from two items specifically 
assessing nutrition in SCI-SD. The nutrition score was added in the previous study in 
order to isolate the unique contribution of this construct, considering problems with 
nutrition which children with SCD experience (Brown et al., 1993; Finan et al., 1988). 
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Higher scores on SCI-SC indicate better level of adherence. The SCI-SC is considered a 
reliable and valid measure of adherence in SCD care behaviors (Hilker et al., 2006). It 
had adequate internal consistency (Cronbach’s α= .701) in the current study. In addition, 
no group difference was found (F (1, 80)= .042, p= .837) between the younger age group 
(6-9 years old) and the older age group (10-12 years old) on their adherence behaviors.  
The Pediatric Quality of Life Inventory. The Pediatric Quality of Life 
Inventory (PedsQL; Varni et al., 1999) is a 23-item caregiver proxy and child self-report 
which assess a child’s quality of life on a 5-point Likert scale. The PedsQL consists of 
four subscales: Physical functioning, Emotional functioning, Social functioning, and 
School functioning and yields three summary scores including physical health, 
psychosocial health (emotional, social, and school functioning), and a total summary 
score. Higher scores on PedsQL indicate better quality of life. The total summary scores 
were used in the analysis. The measure has been validated in healthy and chronically ill 
populations (Varni et al., 2001). It had good internal consistency (Cronbach’s α= .859) 
based on child self-report on HRQoL total score and excellent internal consistency based 
on caregiver proxy-report total score (Cronbach’s α= .903) (see Table 2). Rating 
agreement was assessed between total summary scores from child and caregiver reports, 
using bivariate correlations and intra-class correlation coefficients. The caregiver proxy 
and child self-report total scores were examined separately in further analyses due to non-
significant correlation (t(81)= -.95, p= .345). 
The Wechsler Abbreviated Scale of Intelligence. The Wechsler Abbreviated 
Scale of Intelligence (WASI) is a brief measure of intelligence for individuals age 6 to 89 
years (Ryan & Brown, 2005). The original study used the two-subtest form including 
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Vocabulary and Matrix Reasoning subtests. The sum of the t scores of the subtests was 
used in the analysis. The WASI is a reliable and valid measure of intelligence (Canivez, 
Konold, Collins, &Wilson, 2009; Ryan & Brown, 2005). 
The Woodcock-Johnson-III. The Woodcock-Johnson-III (WJ-III) is a measure 
of academic achievement for individuals age 2 through 90 years (Grenwelge, 2009). 
Reliability measures indicate Cronbach alpha’s of .80 or higher (Grenwelge, 2009). 
Subsets of the WJ-III Tests of Achievement were chosen and used for the previous study, 
including Calculation, Spelling, Letter-Word Identification, Reading Fluency, Math 
Fluency, and Passage Comprehension. Academic skills (Letter-Word Identification, 
Calculation, and Spelling) was scored according to the WJ-III manual and used in the 
current analysis as an indicator for academic functioning. The WJ-III Tests of 
Achievement have been used in previous studies to measure academic functioning 
(Schatz, 2004) and are considered a standard measure of academic achievement for 
children with SCD (Daly, Kral, & Tarazi, 2011). 
The Hematology/Oncology Psycho-educational Needs Assessment. The 
Hematology/Oncology Psycho-educational (HOPE) Needs Assessment (Peterson, 
Palermo, Swift, Beebe, & Drotar, 2005) consists of 17 items assessing areas of 
academic/school functioning, including learning problems, functional impairment, 
behavioral concerns at school, and evaluation of current services. Selected items that 
were related to prevention and interventions were used in the current study to address 
academic needs. A total score of the 7 selected items was used in the analysis. 
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Procedure 
Participants and caregivers were recruited during outpatient clinic visits, inpatient 
hospital stays, and SCD community events between 2009 and 2012. Assent and consent 
forms were obtained from children and their caregivers. Assessments were conducted in 
the family home or in an outpatient medical setting during clinic visits. The previous 
study protocol was approved by the Human Subjects Committees of Drexel Institutional 
Review Boards (IRB). The current study was a secondary analysis  
Data Analysis Plan  
Descriptive and Preliminary Analyses. Preliminary analysis (i.e., descriptives) 
examined the baseline data set and identified any outliers. Bivariate correlations and One-
way ANOVAs were run to assess the relationships between demographic variables (e.g., 
child age, child gender, child’s grade at school, SCD genotype grouped based on disease 
severity, family total annual income, caregiver’s education level) and outcome variables 
(i.e., HRQoL measure) in order to identify any potential covariates. Identified covariates 
were controlled in further analyses. Bivariate correlations and intra-class correlation 
coefficients (ICCs) were used to examine rater agreement on the HRQoL measure (i.e., 
PedsQL) to identify caregiver proxy and child self-report total summary scores with fair 
or poor rater concordance based on the recommendation from the literature (e.g., 
Chambers et al., 1998). An ICC of 0.75 was used to differentiate good and fair or poor 
agreement (Lee et al., 1989). The total scores with fair or poor rater agreement were 
examined in the moderation model as outcome variables separately. 
Primary Analyses. Relationships between the independent variable (i.e., 
adherence behaviors), moderators (i.e., cognitive functioning, academic functioning, 
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academic needs), and dependent variable (i.e., HRQoL) were examined, using bivariate 
correlations. Assumptions of moderation were also checked prior to using the Process 
Macro (Hayes, 2015) in Statistical Package for the Social Science (SPSS) V.24 and no 
violation was found. The independent variable, moderators, and dependent variable were 
continuous variables. Linearity between the factor (i.e., adherence) and outcome variable 
(i.e., HRQoL) was assessed using scatter plot. Normality of the residuals was assessed 
using Q-Q plots. Utilizing Process Macro (Hayes, 2015), independent variables were 
centered to facilitate interpretation and multicollinearity was avoided. Lastly, scatter plots 
were used to assess autocorrelation and homoscedasticity. 
Post-hoc Power Analyses. Using G*Power analysis (Faul et al., 2013), the 
current study achieved a power of .83 based on a sample size of 82, with two predictors 
and one interaction, a medium effective size (f2=.15), and α level at .05 for each 
moderation model.  
Results 
Descriptive and Preliminary Analyses 
Descriptive Statistics. Descriptives were used to assess outliers and missing data 
(see Table 1). One family was excluded due to missing information on a child self-report 
on the HRQoL (i.e., PedsQL). Skewness and Kurtosis were examined to assess 
distribution normality of variables of interest (i.e., adherence, child HRQoL, cognitive 
functioning, academic functioning, and academic needs). No significant skewness was 
identified.  
Covariates. Pearson correlations assessed the relationship between continuous 
demographic variables (i.e., child’s age, family’s total annual income per year) and 
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outcome variables to identify potential covariates (see Table 4). Child self-report on 
HRQoL was significantly related to child age (r= .27, p=.015). Caregiver proxy-report on 
child HRQoL was significantly related to family total annual income (r= .22, p= .045). 
These two variables were controlled for in the moderation analyses. The relationships 
between outcome variables and categorical demographic variables (i.e., child’s gender, 
child’s grade at school, child’s race, SCD genotype, caregiver’s race, and caregiver’s 
education level) were also assessed, using One-Way ANOVAs (see Table 4). No 
violations of ANOVA assumptions were found. No significance relationships were found 
and therefore these demographic variables were not included in further analyses. 
PedsQL Child and Caregiver Informants Correlation and ICCs. Mean scores 
of child HRQoL by child (M= 68.10, SD= 16.73) and caregiver participants (M= 70.41, 
SD= 17.01) was relatively lower as compared to findings from a healthy sample (child 
self-report M= 83.00, SD= 14.79; caregiver proxy-report M= 87.61, SD= 12.33; Varni et 
al., 2001). No significant differences were found between child self-report and caregiver 
proxy report (t(81)= -.95, p= .345). When using the PedsQL total summary scores, no 
significant correlation was found between child self-report and caregiver proxy-report (r= 
.15, p= .180) (see Table 5). In the current sample, a significant group difference was 
found (F(1, 80)= 7.035, p= .010) between the younger age group (6-9 years old) and the 
older age group (10-12 years old), with older child participants (M= 74.01, SD= 13.82) 
rated higher on their HRQoL than their younger peers (M= 64.32, SD= 17.45) (see Table 
3). Therefore, as indicated in the data analysis plan, child self-report and caregiver proxy-
report on the child PedsQL were used separately as outcome variables in the moderation 
analyses. However, further exploration of the sub-domains revealed a significant 
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correlation between child self-report and caregiver proxy-report on child’s physical 
functioning, but no association on child’s psychosocial functioning (see Table 5). 
Primary Analyses 
Aim 1. Caregiver ratings of adherence was positively correlated with child 
HRQoL (r= .34, p= .002), indicating that better adherence was significantly associated 
with better HRQOL. This finding partially supports the hypothesis and is consistent with 
findings in Fisak and colleagues’ (2010) study that found better adherence was associated 
with better child HRQoL. However, no correlation was found between adherence and 
child self-report for HRQoL (r= -.01, p= .929). As such, the lack of a significant 
relationship does not provide full support for the hypothesis. 
Aim 2. As no significant correlation was found between child self-report and 
caregiver proxy-report for child HRQoL, total summary scores from both informants 
were included as outcome variables in each moderation model, respectively (see Table 7-
12). In models using child self-report, child’s age was controlled. When caregiver proxy-
report was included as an outcome variable, family total annual income was controlled 
for. No significant moderation effects were found for cognitive functioning, academic 
functioning, and academic needs. Although the interaction effect was significant for 
academic functioning, neither of the main effects were significant, making the finding 
uninterpretable.  
Explorative Analyses. Through Pearson correlations (see Table 6), caregiver 
proxy-report on child’s overall HRQoL was significantly associated with academic 
functioning (r= .28, p= .010) and academic needs (r= -.32, p= .003). Children who 
perform better at school and receive fewer accommodations may be perceived as better 
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functioning by their caregivers, particularly as the PedsQL total score includes school 
functioning domain. Moreover, academic needs was found significantly related with 
adherence (r= -.37, p= .001) (see Table 6), suggesting that in school-aged children, fewer 
academic accommodations might be associated with better adherence. 
Discussion 
The current study results partially supported Aim 1. However no significantly 
results were found for Aim 2 and explorative aim. The extant literature indicates that 
children with SCD experience impaired HRQoL as compared to healthy peers (Dale et 
al., 2011; Palermo et al., 2002). In the current study, older child participants rated their 
HQRoL higher. In contrast, caregivers rated their child’s HRQoL lower when the child. 
This finding is consistent with results from the Damiper and colleagues’ study (2010) 
which found declining HRQoL scores across ages. 
Disease management requires that children with SCD engage and adhere to a 
myriad of treatment regimens with various invasiveness and intensity (Barakat et al., 
2006). Of the few studies that examined the relationship between adherence to treatment 
and child’s HRQoL in an SCD population, the results are mixed (e.g., Barakat et al., 
2005; Fisak at al., 2010). In their study, Fisak and colleagues (2010) utilized caregiver 
proxy-report of child HRQoL and scores from the Adherence & Self-Care Inventory 
(ASCI) as completed by caregivers. Results revealed a positive association between 
adherence and child’s HRQoL. In contrast, results from another study found that better 
adherence was associated with poorer HRQoL when using caregiver proxy-report on 
child HRQoL (Barakat et al., 2005), suggesting that higher levels of adherence might 
interfere with a child’s preferred physical and social activities (Barakat et al., 2005).  
20 
  
The current study examined the relationship between adherence and child HRQoL 
in a sample of school-aged children with SCD. Using caregiver proxy-report of child 
HRQoL, the result was consistent with previous studies that found higher levels of 
adherence is associated with better HRQoL (e.g., Du Treil, Rice, Leissinger, 2007), 
partially supporting the hypothesis. When using child self-report, there was no 
association between adherence and HRQoL. One explanation for this finding is that 
children in the current study did not fully link adherence with their HRQoL. Potentially, 
the age group of the current sample has not fully captured the importance of adherence 
and equipped with adequate cognitive maturity to consider the impact of treatment 
adherence on their HRQoL. Differences in the relationship between adherence and 
HRQoL could stem from the different perspectives of caregivers and children when 
considering HRQoL. In the Barakat and colleagues (2005) study, the authors suggested 
that adherence could interfere with a child’s physical and social activities. In contrast, 
caregivers might assess HRQoL based on relief of disease symptoms and number of 
hospitalizations. From the child’s perspective it is possible that time spent in receiving 
routine treatment at clinics further reduces the time they can spend engaging in activities 
he/she enjoys.  
Communication between child and caregiver, especially in regard to the child’s 
social-emotional functioning, is critical in meeting the child’s needs and improving 
his/her life quality.  The current study used the total summary score from the PedsQL as a 
measure of child HRQoL, which could be another explanation for the difference in 
findings. The PedsQL total summary score is a composite of a child’s physical, 
emotional, social, and school functioning. Although the total summary score may capture 
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a child’s overall HRQoL, it can potentially mask the difference amongst various aspects 
of a child’s HRQoL and functioning. Indeed, Hommel and colleagues (2008) examined 
medication adherence and quality of life in adolescents with Inflammatory Bowel 
Disease. They found that nonadherence to 6-MP/azathioprine was related to poorer child-
reported physical health quality of life while better adherence to 5-ASA was related to 
poorer overall psychological health quality of life (Hommel et al., 2008). Furthermore, 
children expressed that the burden of taking medication interfered with their daily 
activities and social interactions, especially when symptoms were not present (Penza-
Clvve et al., 2009). The variability in findings between the current study and the past 
study (i.e., Barakat et al., 2005) in assessing adherence and caregiver proxy-report on 
child HRQoL could also stem from differences in measures used for assessing adherence 
and child HRQoL. For example, the different measures may be assessing difference 
aspects of the constructs. The adherence measure used in the current study was completed 
by caregivers only while in Barakat and colleagues’ study, feedback from various 
informants was incorporated (e.g., caregiver and physician). In addition, measure 
assessing child’s competency was used to indicate child HRQoL in the past study (i.e., 
Barakat et al., 2005), which could potentially captured different areas of a child’s HRQoL 
than the PedsQL did.  
Treatment adherence is critical to a child’s overall well-being and life expectancy, 
especially when afflicted with life-threatening diseases. From a child’s perspective, 
adherence may interfere with his/her physical and psychosocial functioning. However, 
from a medical professional’s perspective, it is important to emphasize the benefits of 
treatment adherence (e.g., reductions in physical symptoms). To acknowledge and 
22 
  
address challenges a child may face when adhering to treatment regimens, medical and 
psychological professionals can provide education on benefits of adherence as well as 
guidance and support in adjusting physical and social activities that equivalently meet a 
child’s needs without compromising treatment adherence. Based on the pediatric self-
management model, Modi and colleagues (2012) discussed the impact of self-
management on treatment adherence. Although some characteristics are not changeable 
(e.g., child’s age, gender), some are modifiable (e.g., decision-making, coping strategies, 
family interaction, peer relationship), in which provides opportunities for clinicians to 
carry targeted preventions and interventions to enhance children’s self-management 
skills. As a result, we might see more consistent and sustained treatment adherence in 
pediatric population. Additionally, studies of ratings agreement between children with 
chronic illness and their caregivers have found moderate agreement (r>.50) for scales 
measuring physical functioning, but poor rating agreement (r<.30) on scales measuring 
emotional and social functioning (Eiser & Morse, 2001). Given this variability, it is 
important for medical and psychological providers to consider and integrate perspectives 
from both informants when assessing a child’s HRQoL. 
Children with SCD are at risk for deficits in cognitive functioning and academic 
achievement (Lemanek, Ranalli, Roberts, & Steele, 2009). To further explore adherence 
and HRQoL, the current study examined the role of cognitive and academic functioning 
and academic needs in influencing treatment adherence and its relationship with HRQoL. 
Past research (e.g., Gil et al., 2003) has shown that youth with SCD experience impaired 
school activity and HRQoL. In particular, findings from one study indicated that youth 
who didn’t consciously and actively adhere to pain management related coping strategies 
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(e.g., hydration and resting) experienced more impaired quality of life (e.g., severe pain 
and stress), were less active, and utilized more health care services (Gil et al., 1989). 
Children with higher academic functioning may desire more school and social 
engagement. Adherence to treatment, and in particular preventative disease management, 
can interfere with their engagement at school, physical activity, and potentially peer 
interactions, which could be reflected in their perception of their overall HRQoL.  
A similar pattern was found when assessing cognitive function as a moderator 
(although not statistically significant). Children with higher levels of cognitive 
functioning may be more aware of challenges that arise from SCD and its related 
management regimen as well as the impact of adherence on their HRQoL. The patterns 
found in the moderation models could potentially be explained by the burdens from 
maintaining adherence to treatment, performance at school, and HRQoL. Children with 
SCD, especially school-aged kids, may experience challenges in meeting adherence 
requirements while also actively engaging at school. As mentioned earlier, some 
preventative treatment regimens interfere with children’s physical and social activities. In 
addition, medical routine treatments take away time from engaging in activities. Another 
explanation could be the choice of measures used in the study. Two WASI subtests were 
used in the original study to assess child participants’ IQ level, which might not be the 
ideal indicator of a child’s overall cognitive functioning. Executive functioning as 
explored in Tarazi and colleagues (2007) could potentially be a good representation of a 
child’s cognitive functioning, particularly when investigating treatment adherence as it 
requires cognitive capabilities (e.g., planning, time management).  
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Lastly, no significant result was found in the moderation analysis when using 
academic needs (M= 2.45, SD= 1.92, Min= 0.00, Max= 7.00) as a moderator. The 
majority of the participating families were African-American from low-income 
backgrounds and the child participants were likely attended under-resourced schools. It is 
possible that participating children were in need of additional academic support and 
interventions, but some families might not have sought academic accommodations due to 
a variety of reasons (e.g., no interest, financial burden, busy schedule). It is also possible 
that schools these children attend are not able to provide accommodations either due to 
financial reason or inadequate staff support. As such, the total score of selected items on 
HOPE Needs Assessment might not accurately captured the reality of academic needs 
and accommodations provided for school-aged children with SCD. 
Limitations and Future Directions 
The current study utilized a pre-existing data set. The original study considered 
many variables (e.g., time constraint) when selecting measures to assess child cognitive 
function and academic functioning. Additionally, the aim of the original study was to 
assess the efficacy of a problem-solving intervention for families while the current 
study’s primary was to assess adherence and HRQoL. Future research should consider 
utilizing batteries that better capture and reflect a child’s cognitive and academic 
functioning (e.g., executive functioning vs. overall IQ level; comprehensive assessment 
on math, vocabulary, and reading comprehension). Environmental variables (e.g., 
availability of academic accommodations at school) should be taken into consideration 
when investigating academic needs. The current study used all continuous variables in 
the moderation analyses which achieved less than ideal statistical power, compared to 
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using categorical moderators. Future research should consider variable recoding or select 
measures which can better facilitate moderation analysis. Lastly, the current study was a 
cross-sectional study, in which no causation could be drawn from the results. 
Children with SCD are at risk for cognitive and academic deficits, experience 
lower HRQoL stemming from their disease and related treatments plans, and face 
challenges in adhering to treatment regimens. Future research should further explore the 
influence of cognitive and academic functioning on treatment adherence, particularly 
focusing on early detection and prevention to improve children’s HRQoL.  
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Table 1. Demographic Information (N = 82) 
Child Demographic Information 
 Mean (M)/ Frequency (n) Percent (%) 
Age 8.49 (SD= 2.12) -- 
Gender   
Male 41 50.0 
Female 41 50.0 
Race   
African-American/Black 77 93.9 
Other 5 6.1 
Genotype   
HbSS 49 59.8 
HbSC 24 29.3 
HbSβ+ 6 7.3 
HbSβ0 1 1.2 
Other 2 2.4 
Caregiver Demographic Information 
 Mean (M)/ Frequency (n) Percent (%) 
Female 77 93.9 
African-American/Black 78 95.1 
Education (high school or higher) 82 100.0 
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Table 2. Internal Consistency of HRQoL Measure (N = 82) 
 Physical Summary 
Score (α) 
Psychosocial Summary 
Score (α) 
Total Score 
(α) 
Child Self-report  .64 .83 .86 
Caregiver Proxy-
report 
.87 .85 .90 
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Table 3. Age Differences on HRQoL Total Score (N = 82) 
 6-9 Years Old 
(M) 
10-12 Years Old 
(M) 
Combined 
(M) 
Child Self-report 64.32 (SD= 17.45) 74.01 (SD= 13.82) 68.10 (SD= 16.73) 
Caregiver Proxy-
report 
72.52 (SD= 16.57) 67.12 (SD= 17.42) 70.41 (SD= 17.01) 
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Table 4. Correlations between Demographic Variables with HRQoL (N = 82) 
 Child’s 
Age 
Child’s 
Gender 
Child’s 
Race 
Child’s 
Grade 
SCD 
Genotype 
Family 
Total 
Annual 
Income 
Caregiver 
Highest 
Education 
Level 
Child  
Self-report 
on Child 
HRQoL 
 
r= .27* 
 
 
F= 1.88 
 
F= .10 
 
F= 1.85 
 
F= 2.00 
 
r= -.18 
 
F= .75 
 
Caregiver 
Proxy-
report on 
Child 
HRQoL 
 
 
r= -.11 
 
 
F= .10 
 
 
F= .02 
 
 
F= 1.36 
 
 
F=1.35 
 
 
r= .22* 
 
 
F= .69 
Note. *Significance level p≤ .05. 
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Table 5. Correlations on HRQoL Domains between Informants (N = 82) 
 Caregiver-report 
Physical 
Caregiver-report 
Psychosocial 
Caregiver-report 
Total 
Child-report 
Physical 
r= .22* 
 
  
Child-report 
Psychosocial  
r= .17 
 
 
Child-report  
Total 
  
r= .15 
 
Note. * Significance level p≤ .05. 
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Table 6. Correlations between Key Variables (N = 82) 
 Cognitive 
Functioning 
Academic 
Functioning 
Academic Needs 
Adherence r= .09 r= .14 r= -.37* 
Child-report 
HRQoL Total 
r= -.05 r= -.02 r= .13 
Caregiver-report 
HRQoL Total 
r= .06 r= .28* r= -.32* 
Note. * Significance level p≤ .05. 
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Table 7. Child Self-report on HRQoL Predicted by Adherence and Cognitive 
Functioning (N = 82) 
 β p 95% CI 
Constant 50.33 .000 34.58    66.08 
Adherence -.02 .987    -2.28    2.24 
Academic Functioning -.00 .983      -.29    .28 
Adherence x Cog Functioning -.07 .417      -.24    .10 
Note. Controlled for Child Age 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
40 
  
 
 
 
 
Table 8. Child Self-report on HRQoL Predicted by Adherence and Academic 
Functioning (N = 82) 
 β p 95% CI 
Constant 50.39 .000  33.91     66.87 
Adherence .19 .869 -2.04     2.41 
Academic Functioning -.04 .716       -.24     .17 
Adherence x Aca Functioning -.12   .024*       -.22     -.02 
Note. Controlled for Child Age * Significance level p≤ .05. 
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Table 9. Child Self-report on HRQoL Predicted by Adherence and Academic Needs  
(N = 82) 
 β p 95% CI 
Constant 51.18 .000   35.52    66.83 
Adherence .20 .878    -2.40    2.80 
Academic Needs .80 .461    -1.35    2.96 
Adherence x Academic Needs .31 .635      -.99    1.61 
Note. Controlled for Child Age 
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Table 10. Caregiver Proxy-report on HRQoL Predicted by Adherence and Cognitive 
Functioning (N = 82) 
 β p 95% CI 
Constant 65.68 .000 59.38   71.97 
Adherence 2.80 .004     .90    4.70 
Cognitive Functioning .00 .997       -.25    .25 
Adherence x Cog Functioning -.04 .659       -.20    .13 
Note. Controlled for Family Annual Income 
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Table 11. Caregiver Proxy-report on HRQoL Predicted by Adherence and Academic 
Functioning (N = 82) 
 β p 95% CI 
Constant 66.97 .000 60.40   73.54 
Adherence 2.45 .014   .50    4.39 
Academic Functioning .23 .047        .00    .46 
Adherence x Aca Functioning .03 .663       -.98    .17 
Note. Controlled for Family Annual Income 
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Table 12. Caregiver Proxy-report on HRQoL Predicted by Adherence and Academic 
Needs (N = 82) 
 β p 95% CI 
Constant 65.61 .000 59.59   71.63 
Adherence 1.99 .053       -.02   4.00 
Academic Needs -2.08 .052     -4.18    .02 
Adherence x Academic Needs .04 .947     -1.10    1.18 
Note. Controlled for Family Annual Income 
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